The SARS-CoV-2 pandemic has demonstrated the need for increasing the diversity of ways to produce monoclonal antibody-based diagnostics and therapeutics against emerging viruses. This study was perfor
The SARS-CoV-2 pandemic has demonstrated the need for increasing the diversity of ways to produce monoclonal antibody-based diagnostics and therapeutics against emerging viruses. This study was perfor
